AARS2 | Alanyl-tRNA synthetase 2, mitochondrial | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARHGAP35 | Rho GTPase activating protein 35 | Cancer-related genes
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BARD1 | BRCA1 associated RING domain 1 | Cancer-related genes Plasma proteins
| | | | | Mixed |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CCAR1 | Cell division cycle and apoptosis regulator 1 | Cancer-related genes
| | | | | Expressed in all |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CDKN2C | Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CFH | Complement factor H | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHD4 | Chromodomain helicase DNA binding protein 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CIC | Capicua transcriptional repressor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
CLTC | Clathrin, heavy chain (Hc) | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CREB1 | CAMP responsive element binding protein 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CSDE1 | Cold shock domain containing E1, RNA-binding | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CTCF | CCCTC-binding factor (zinc finger protein) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CTNND1 | Catenin (cadherin-associated protein), delta 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CTTN | Cortactin | Cancer-related genes Cytoskeleton related proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CUL1 | Cullin 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
DDX5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
DHX9 | DEAH (Asp-Glu-Ala-His) box helicase 9 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
DMD | Dystrophin | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Mixed |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
DOCK2 | Dedicator of cytokinesis 2 | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Mixed |
EEF1A1 | Eukaryotic translation elongation factor 1 alpha 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | Cancer-related genes Transcription factors
| | | | | Mixed |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
EWSR1 | EWS RNA-binding protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |